Tom Stuttaford questions whether further government investment is enough to successfully combat breast cancer
Several years ago, the French government arranged an international meeting in Paris to discuss the latest treatments available to treat breast cancer. There were senior representatives from the ministries of health from the major countries in Europe, as well as many from farther afield. There was one exception. Britain didn’t send any minister or other politician. We were represented by one junior civil servant, together with a bunch of journalists. The omission had been noted by our hosts. A senior French government official, in his introductory welcome, suggested that Britain was always moaning about its relatively poor results in breast cancer treatment. But, he said, the reason for this was obvious: its authorities either didn’t know of, or didn’t care to provide, the best possible regime that would give an affected woman the best chance of survival. We are catching up but still lag behind other countries, including those that...
I’m afraid this isn’t one of our four free articles available in full, which are set out in the first two rows of the ‘Magazine’ page.
Please click here to find them.
To buy a digital version of this issue for just £2.99, click here
